|
CWC15 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.39500000000148E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.002010E-03 |
| Normal-vs-Stage2 |
2.335700E-03 |
| Normal-vs-Stage3 |
2.24979999996489E-06 |
| Normal-vs-Stage4 |
1.80716000000025E-05 |
| Stage1-vs-Stage2 |
2.693600E-01 |
| Stage1-vs-Stage3 |
2.214100E-02 |
| Stage1-vs-Stage4 |
4.267900E-02 |
| Stage2-vs-Stage3 |
8.461600E-01 |
| Stage2-vs-Stage4 |
7.117400E-01 |
| Stage3-vs-Stage4 |
7.896000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.40939999995859E-06 |
| Normal-vs-AfricanAmerican |
6.563500E-03 |
| Normal-vs-Asian |
3.838800E-01 |
| Caucasian-vs-AfricanAmerican |
9.050600E-01 |
| Caucasian-vs-Asian |
1.284360E-03 |
| AfricanAmerican-vs-Asian |
5.949600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.87939999999731E-05 |
| Normal-vs-Female |
1.237370E-04 |
| Male-vs-Female |
2.947000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.120700E-03 |
| Normal-vs-Age(41-60Yrs) |
8.44550000000943E-05 |
| Normal-vs-Age(61-80Yrs) |
2.48229999999516E-07 |
| Normal-vs-Age(81-100Yrs) |
1.077090E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.181600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.392300E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.382000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.680500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.137030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.360600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.007800E-01 |
| Classical-VS-Follicular |
6.355800E-01 |
| Classical-VS-Other |
1.403410E-01 |
| Classical-VS-Normal |
1.631560E-04 |
| Tall-VS-Follicular |
5.411000E-01 |
| Tall-VS-Other |
2.937600E-02 |
| Tall-VS-Normal |
4.566300E-04 |
| Follicular-VS-Other |
3.906100E-02 |
| Follicular-VS-Normal |
1.001180E-03 |
| Other-VS-Normal |
9.138200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.55389999999733E-05 |
| Normal-vs-N1 |
3.078400E-02 |
| N0-vs-N1 |
1.429790E-01 |
|
|
